Taken together, these findings support a notion that downregulation of B7H3 is associated with reduced VEGFA in IDH-mutated gliomas, and B7H3 and VEGFA further decrease in IDH-mutated gliomas with highly accumulated 2-HG level. The gene discussed is VEGFA; the disease is central nervous system cancer.